Inventor · disambiguated record
Mark R. Player
Also filed as: PLAYER MARK · PLAYER MARK R
35 granted patents·11 pending applications·408 citations·filing 1997–2020
97Inventor score
Files withJANSSEN PHARMACEUTICA NV26PLAYER MARK R8BOEHRINGER INGELHEIM PHARMA3CALVO RAUL R2BIGNAN GILLES1
Top patents by PatentIndex Score
46 records- 0194US9067898B1Isothiazole derivatives as GPR120 agonists for the treatment of type II diabetesJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jun 30, 2015·13 cites·20 claims
- 0294US7608622B2Imidazo[4,5-b]pyrazinone inhibitors of protein kinasesJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Oct 27, 2009·53 cites·6 claims
- 0393US7790724B2c-fms kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Sep 7, 2010·26 cites·9 claims
- 0493US6214805B1RNase L activators and antisense oligonucleotides effective to treat RSV infectionsUS HEALTH·Filed 1997·Granted Apr 10, 2001·174 cites·15 claims
- 0591US7829584B2Pyridines and pyridine N-oxides as modulators of thrombinJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Nov 9, 2010·12 cites·10 claims
- 0686US7262210B2Fluorinated pyridine N-oxide thrombin modulators and process for N-oxidation of nitrogen containing heteroarylsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Aug 28, 2007·9 cites·8 claims
- 0785US7429603B2C-fms kinase inhibitorsDIMENSIONAL PHARM INC·Filed 2004·Granted Sep 30, 2008·29 cites·2 claims
- 0885US7321041B21,6 Naphthyridines useful as inhibitors of SYK kinaseBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Jan 22, 2008·23 cites·6 claims
- 0983US7951829B2Benzimidazole modulators of VR1JANSSEN PHARMACEUTICA NV·Filed 2007·Granted May 31, 2011·6 cites·17 claims
- 1083US7678911B21,6 naphthyridines useful as inhibitors of SYK kinaseBOEHRINGER INGELHEIM PHARMA·Filed 2008·Granted Mar 16, 2010·6 cites·2 claims
- 1182US9193736B2PDE 10a inhibitors for the treatment of type II diabetesJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Nov 24, 2015·7 cites·14 claims
- 1282US7427683B2c-fms kinase inhibitorsORTHO MCNEIL PHARM INC·Filed 2004·Granted Sep 23, 2008·22 cites·4 claims
- 1381US7705151B21,6 Naphthridines useful as inhibitors of SYK kinaseBOEHRINGER INGELHEIM PHARMA·Filed 2009·Granted Apr 27, 2010·4 cites·2 claims
- 1480US9920040B2GPR40 agonists for the treatment of type II diabetesJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Mar 20, 2018·2 cites·32 claims
- 1580US9908873B2GPR40 agonists for the treatment of type II diabetesJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Mar 6, 2018·2 cites·30 claims
- 1680US9856245B2GPR40 agonists for the treatment of type II diabetesJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Jan 2, 2018·2 cites·31 claims
- 1774US7326788B2Quinolinone derivatives as inhibitors of c-fms kinaseJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Feb 5, 2008·8 cites·6 claims
- 1873US8796256B2Substituted thiazolidinedione indazoles, indoles and benzotriazoles as estrogen-related receptor-α modulatorsBIGNAN GILLES·Filed 2011·Granted Aug 5, 2014·3 cites·28 claims
- 1972US9718820B2Substituted aza-bicyclic imidazole derivatives useful TRPM8 receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Aug 1, 2017·1 cites·19 claims
- 2071US7642270B25-oxo-5,8-dihydro-pyrido-pyrimidine as inhibitors of c-fms kinaseJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Jan 5, 2010·1 cites·12 claims
- 2170US8680098B2Substituted aza-bicyclic imidazole derivatives useful as TRPM8 receptor modulatorsPLAYER MARK R·Filed 2011·Granted Mar 25, 2014·2 cites·24 claims
- 2269US8217060B2Benzimidazole derivatives useful as TRP M8 receptor modulatorsCALVO RAUL R·Filed 2010·Granted Jul 10, 2012·3 cites·12 claims
- 2365US10662170B2Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetesJANSSEN PHARMACEUTICA NV·Filed 2018·Granted May 26, 2020·0 cites·2 claims
- 2459US9023846B2Substituted AZA-bicyclic imidazole derivatives useful as TRPM8 receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted May 5, 2015·0 cites·11 claims
- 2558US10131648B2Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetesJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Nov 20, 2018·0 cites·14 claims
- 2653US9790198B2Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetesJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Oct 17, 2017·0 cites·22 claims
- 2753US2024109910A1HEXAHYDRO-5,8-EPOXYCYCLOHEPTA[c]PYRAZOLE DERIVATIVES USEFUL AS MODULATORS OF THE CB1 AND / OR CB2 RECEPTORSJANSSEN PHARMACEUTICA NV·Filed 2020·Application pending·0 cites
- 2851US10988433B2Cyclohexyl GPR40 agonists for the treatment of type II diabetesJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Apr 27, 2021·0 cites·44 claims
- 2951US9409915B2Substituted aza-bicyclic imidazole derivatives useful as TRPM8 receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Aug 9, 2016·0 cites·14 claims
- 3050US8232409B2Heterocyclic benzimidazoles as TRPM8 modulatorsPLAYER MARK R·Filed 2009·Granted Jul 31, 2012·0 cites·40 claims
- 3149US2003158195A11,6 naphthyridines useful as inhibitors of SYK kinaseFiled 2001·Application pending·0 cites
- 3249US2010113473A1Aryl amide compound as an acetyl coenzyme a carboxylase inhibitorPLAYER MARK R·Filed 2009·Application pending·0 cites
- 3348US9249163B2PDE10a inhibitors for the treatment of type II diabetesJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Feb 2, 2016·0 cites·19 claims
- 3447US7612211B2Benzimidazole TRPV1 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Nov 3, 2009·0 cites·27 claims
- 3546US7446210B2Factor Xa compoundsJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Nov 4, 2008·0 cites·13 claims
- 3646US2011190364A1Benzimidazole modulators of vr1PLAYER MARK R·Filed 2011·Application pending·0 cites
- 3746US2011190344A1Benzimidazole modulators of vr1PLAYER MARK R·Filed 2011·Application pending·0 cites
- 3844US2005113566A1Inhibitors of C-FMS kinaseFiled 2004·Application pending·0 cites
- 3941US7728003B25-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of c-fms kinaseJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Jun 1, 2010·0 cites·8 claims
- 4041US2004110758A14,6-Diaminosubstituted-2-[oxy or aminoxy]-[1,3,5]triazines as protein tyrosine kinase inhibitorsFiled 2003·Application pending·0 cites
- 4141US2008114007A15-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of c-fms kinasePLAYER MARK R·Filed 2007·Application pending·0 cites
- 4240US10106553B2Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetesJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Oct 23, 2018·0 cites·19 claims
- 4338US2006116368A14-Piperidinecarboxamide modulators of vanilloid VR1 receptorCALVO RAUL R·Filed 2005·Application pending·0 cites
- 4436US9688642B2Substituted pyrazines as GPR40 agonistsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Jun 27, 2017·0 cites·19 claims
- 4536US2012202856A1Substituted benzimdazole derivatives useful as trpm8 receptor modulatorsPLAYER MARK R·Filed 2012·Application pending·0 cites
- 4635US2006014812A1Use of estrogen related receptor-modulating aryl ethersPLAYER MARK R·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark R. Player files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →